Literature DB >> 26015929

Optimal management of sentinel lymph node positive biopsy patients in early breast cancer.

Geraldine M Jacobson1, Jessica F Partin1, Mohamad A Salkeni1.   

Abstract

Entities:  

Year:  2015        PMID： 26015929      PMCID： PMC4430736          DOI： 10.3978/j.issn.2305-5839.2015.02.33

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  19 in total

1.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Authors:  Bernard Fisher; Jong-Hyeon Jeong; Stewart Anderson; John Bryant; Edwin R Fisher; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

Review 2.  Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis.

Authors:  Mona Sanghani; Ethan M Balk; Blake Cady
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

Review 3.  Timing of determining axillary lymph node status when neoadjuvant chemotherapy is used.

Authors:  Eleftherios P Mamounas
Journal:  Curr Oncol Rep       Date:  2014-02       Impact factor: 5.075

4.  Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation.

Authors:  P J Schlembach; T A Buchholz; M I Ross; S M Kirsner; G J Salas; E A Strom; M D McNeese; G H Perkins; K K Hunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-01       Impact factor: 7.038

5.  Effect of axillary lymphadenectomy on breast carcinoma survival.

Authors:  Sue A Joslyn; Badrinath R Konety
Journal:  Breast Cancer Res Treat       Date:  2005-05       Impact factor: 4.872

6.  Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer.

Authors:  Pauline T Truong; Vanessa Bernstein; Elaine Wai; Boon Chua; Caroline Speers; Ivo A Olivotto
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

7.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

8.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Authors:  Viviana Galimberti; Bernard F Cole; Stefano Zurrida; Giuseppe Viale; Alberto Luini; Paolo Veronesi; Paola Baratella; Camelia Chifu; Manuela Sargenti; Mattia Intra; Oreste Gentilini; Mauro G Mastropasqua; Giovanni Mazzarol; Samuele Massarut; Jean-Rémi Garbay; Janez Zgajnar; Hanne Galatius; Angelo Recalcati; David Littlejohn; Monika Bamert; Marco Colleoni; Karen N Price; Meredith M Regan; Aron Goldhirsch; Alan S Coates; Richard D Gelber; Umberto Veronesi
Journal:  Lancet Oncol       Date:  2013-03-11       Impact factor: 41.316

9.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.

Authors:  Judy C Boughey; Vera J Suman; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; A Marilyn Leitch; Henry M Kuerer; Monet Bowling; Teresa S Flippo-Morton; David R Byrd; David W Ollila; Thomas B Julian; Sarah A McLaughlin; Linda McCall; W Fraser Symmans; Huong T Le-Petross; Bruce G Haffty; Thomas A Buchholz; Heidi Nelson; Kelly K Hunt
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

10.  Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.

Authors:  Christine Louis-Sylvestre; Krishna Clough; Bernard Asselain; Jacques René Vilcoq; Remy Jacques Salmon; François Campana; Alain Fourquet
Journal:  J Clin Oncol       Date:  2004-01-01       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.